Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function.

Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme JC, Frey EA, Lario PI, Metalnikov P, Rizg K, Thomas NA, Lee SF, Hartland EL, Hardwidge PR, Pawson T, Strynadka NC, Finlay BB, Schekman R, Gruenheid S.

Cell Host Microbe. 2007 Sep 13;2(3):160-71.

2.

Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA.

Thanabalasuriar A, Bergeron J, Gillingham A, Mimee M, Thomassin JL, Strynadka N, Kim J, Gruenheid S.

Cell Microbiol. 2012 Aug;14(8):1206-18. doi: 10.1111/j.1462-5822.2012.01789.x. Epub 2012 Apr 12.

PMID:
22432415
3.

The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.

Thanabalasuriar A, Kim J, Gruenheid S.

Microbes Infect. 2013 Sep-Oct;15(10-11):738-44. doi: 10.1016/j.micinf.2013.05.001. Epub 2013 Jun 6.

PMID:
23747681
4.

The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.

Thanabalasuriar A, Koutsouris A, Weflen A, Mimee M, Hecht G, Gruenheid S.

Cell Microbiol. 2010 Jan;12(1):31-41. doi: 10.1111/j.1462-5822.2009.01376.x. Epub 2009 Aug 27.

5.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

6.

Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.

Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB.

Mol Microbiol. 2004 Mar;51(5):1233-49.

7.

A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.

Lee SF, Kelly M, McAlister A, Luck SN, Garcia EL, Hall RA, Robins-Browne RM, Frankel G, Hartland EL.

Cell Microbiol. 2008 Feb;10(2):499-513. Epub 2007 Nov 2.

PMID:
17979986
8.

Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.

Nobe R, Nougayrède JP, Taieb F, Bardiau M, Cassart D, Navarro-Garcia F, Mainil J, Hayashi T, Oswald E.

Microbiology. 2009 Oct;155(Pt 10):3214-25. doi: 10.1099/mic.0.030759-0. Epub 2009 Jul 23.

PMID:
19628559
9.

Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.

Loukiadis E, Nobe R, Herold S, Tramuta C, Ogura Y, Ooka T, Morabito S, Kérourédan M, Brugère H, Schmidt H, Hayashi T, Oswald E.

J Bacteriol. 2008 Jan;190(1):275-85. Epub 2007 Sep 14.

10.

Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S, Baruch K, Yerushalmi G, Berdichevsky T, Altuvia S, Elgrably-Weiss M, Abe C, Knutton S, Sasakawa C, Ritchie JM, Waldor MK, Rosenshine I.

J Bacteriol. 2008 Jul;190(14):5063-74. doi: 10.1128/JB.00440-08. Epub 2008 May 23.

11.

The effector repertoire of enteropathogenic E. coli: ganging up on the host cell.

Dean P, Kenny B.

Curr Opin Microbiol. 2009 Feb;12(1):101-9. doi: 10.1016/j.mib.2008.11.006. Epub 2009 Jan 12. Review.

12.

Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.

Yen H, Sugimoto N, Tobe T.

PLoS Pathog. 2015 Sep 2;11(9):e1005121. doi: 10.1371/journal.ppat.1005121. eCollection 2015 Sep.

13.

The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.

Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, Sham HP, Vallance BA, Foster LJ, Finlay BB.

Cell Microbiol. 2010 Sep 1;12(9):1322-39. doi: 10.1111/j.1462-5822.2010.01470.x. Epub 2010 Mar 31.

PMID:
20374249
14.

A rapid and quantitative coat protein complex II vesicle formation assay using luciferase reporters.

Fromme JC, Kim J.

Anal Biochem. 2012 Feb 15;421(2):482-8. doi: 10.1016/j.ab.2011.12.030. Epub 2011 Dec 24.

PMID:
22244805
15.

Dual infection system identifies a crucial role for PKA-mediated serine phosphorylation of the EPEC-Tir-injected effector protein in regulating Rac1 function.

Brandt S, Kenny B, Rohde M, Martinez-Quiles N, Backert S.

Cell Microbiol. 2009 Aug;11(8):1254-71. doi: 10.1111/j.1462-5822.2009.01330.x. Epub 2009 Apr 30.

PMID:
19438518
16.
17.

mBet3p is required for homotypic COPII vesicle tethering in mammalian cells.

Yu S, Satoh A, Pypaert M, Mullen K, Hay JC, Ferro-Novick S.

J Cell Biol. 2006 Jul 31;174(3):359-68.

18.

Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1.

Buss C, Müller D, Rüter C, Heusipp G, Schmidt MA.

Cell Microbiol. 2009 Apr;11(4):661-77. doi: 10.1111/j.1462-5822.2009.01284.x. Epub 2009 Jan 7.

PMID:
19134119
19.

Interaction of the K(+)-channel KAT1 with the coat protein complex II coat component Sec24 depends on a di-acidic endoplasmic reticulum export motif.

Sieben C, Mikosch M, Brandizzi F, Homann U.

Plant J. 2008 Dec;56(6):997-1006. doi: 10.1111/j.1365-313X.2008.03658.x. Epub 2008 Sep 4.

20.

Cytoskeleton-modulating effectors of enteropathogenic and enterohemorrhagic Escherichia coli: a case for EspB as an intrinsically less-ordered effector.

Hamada D, Hamaguchi M, Suzuki KN, Sakata I, Yanagihara I.

FEBS J. 2010 Jun;277(11):2409-15. doi: 10.1111/j.1742-4658.2010.07655.x. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk